Cytek Biosciences Q3 EPS $(0.05) Misses $0.03 Estimate, Sales $48.00M Miss $55.48M Estimate
Portfolio Pulse from bharat@benzinga.com
Cytek Biosciences reported Q3 losses of $(0.05) per share, missing the analyst consensus estimate of $0.03 by 266.67%. The company also reported quarterly sales of $48.00 million, missing the analyst consensus estimate of $55.48 million by 13.48%. This represents a 225% decrease in earnings and an 18.59% increase in sales compared to the same period last year.
November 07, 2023 | 9:32 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cytek Biosciences' Q3 earnings and sales missed analyst estimates, with a significant decrease in earnings compared to last year.
Cytek Biosciences reported a significant miss on both earnings and sales for Q3. This underperformance, especially the 225% decrease in earnings compared to the same period last year, is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100